Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Kingsley Nnanna Ukwaja"'
Evaluation of clinicians’ knowledge of and attitudes to Ebola virus disease in Ebonyi State, Nigeria
Autor:
Nnennaya Anthony Ajayi, Chiedozie Kingsley Ojide, Immanuel Anthony Ajayi, Kingsley Nnanna Ukwaja
Publikováno v:
Journal of Virus Eradication, Vol 5, Iss 3, Pp 145-151 (2019)
Introduction: Ebola virus disease (EVD) remains a global threat of international concern. Being at the frontline of medical care, clinicians are at high risk of infection. Inadequate knowledge of, or poor attitudes to, EVD among clinicians may lead t
Externí odkaz:
https://doaj.org/article/24cddd72f346478ba46f9b0293a02969
Autor:
Ayodeji Olayemi, Akinlabi Oyeyiola, Adeoba Obadare, Joseph Igbokwe, Adetunji Samuel Adesina, Francis Onwe, Kingsley Nnanna Ukwaja, Nnennaya Anthony Ajayi, Toni Rieger, Stephan Günther, Elisabeth Fichet-Calvet
Publikováno v:
Parasites & Vectors, Vol 11, Iss 1, Pp 1-9 (2018)
Abstract Background Lassa fever, killing thousands of people annually, is the most reported viral zoonotic disease in Nigeria. Recently, different rodent species carrying diverse lineages of the Lassa virus (LASV) in addition to a novel Mobala-like g
Externí odkaz:
https://doaj.org/article/12b4fd89ca21462eb939c8838d24e73c
Publikováno v:
PLoS ONE, Vol 12, Iss 7, p e0180996 (2017)
Drug-resistant tuberculosis (TB) undermines control efforts and its burden is poorly understood in resource-limited settings. We performed a systematic review and meta-analysis to provide an up-to-date summary of the extent of drug-resistant TB in Ni
Externí odkaz:
https://doaj.org/article/afd60530570d4724aac61900782a5038
Autor:
Zaid Zoumot, Nasser Al Busaidi, Wail Tashkandi, Ahmed A Aljohaney, Said Isse, Kota Vidyasagar, Kingsley Nnanna Ukwaja
Publikováno v:
Journal of asthma and allergy. 15
Tezepelumab is a human monoclonal antibody that blocks thymic stromal lymphopoietin, an epithelial-cell-derived cytokine implicated in the pathogenesis of asthma. It was approved by the United States Federal Drug Administration (US FDA) as an add-on
Possible artemisinin-based combination therapy-resistant malaria in Nigeria: a report of three cases
Publikováno v:
Revista da Sociedade Brasileira de Medicina Tropical, Vol 46, Iss 4, Pp 525-527 (2013)
Artemisinin-based combination therapy-resistant malaria is rare in Sub-Saharan Africa. The World Health Organization identifies monitoring and surveillance using day-3 parasitaemia post-treatment as the standard test for identifying suspected artemis
Externí odkaz:
https://doaj.org/article/0abebdbd268a44bea9268caede69165f
Publikováno v:
Tuberculosis Research and Treatment, Vol 2014 (2014)
Externí odkaz:
https://doaj.org/article/5cbb8fe43f984a2784e6ed6c7a66bb18
Autor:
Kingsley Nnanna Ukwaja, Isaac Alobu, Ngozi Appolonia Ifebunandu, Chijioke Osakwe, Chika Igwenyi
Publikováno v:
The Pan African Medical Journal, Vol 16, Iss 11 (2013)
Unlike previous annual WHO tuberculosis reports that reported case detection rate for only smear- positive tuberculosis cases, the 2010 report presented case detection rate for all tuberculosis cases notified in line with the current Stop TB strategy
Externí odkaz:
https://doaj.org/article/d7be4c4da4654c2cbd0d4e5f5bb7658a
Publikováno v:
The Pan African Medical Journal, Vol 14, Iss 85 (2013)
Catastrophic costs of the managed hypertensive in Nigeria: a need for further study
Externí odkaz:
https://doaj.org/article/2f714659311e4af69638014517ef9e04
Publikováno v:
International Journal of Environmental Research and Public Health
Volume 16
Issue 20
International Journal of Environmental Research and Public Health, Vol 16, Iss 20, p 3857 (2019)
Volume 16
Issue 20
International Journal of Environmental Research and Public Health, Vol 16, Iss 20, p 3857 (2019)
It remains unclear which factors are instrumental in meeting the recommended physical activity in people with diabetes. We, therefore, aimed to determine the sociodemographic, health-related behavior and clinical factors associated with meeting the r
Global Burden of Multiple Myeloma: A Systematic Analysis for the Global Burden of Disease Study 2016
Autor:
Andrew J, Cowan, Christine, Allen, Aleksandra, Barac, Huda, Basaleem, Isabela, Bensenor, Maria Paula, Curado, Kyle, Foreman, Rahul, Gupta, James, Harvey, H Dean, Hosgood, Mihajlo, Jakovljevic, Yousef, Khader, Shai, Linn, Deepesh, Lad, Lorenzo, Mantovani, Vuong Minh, Nong, Ali, Mokdad, Mohsen, Naghavi, Maarten, Postma, Gholamreza, Roshandel, Katya, Shackelford, Mekonnen, Sisay, Cuong Tat, Nguyen, Tung Thanh, Tran, Bach Tran, Xuan, Kingsley Nnanna, Ukwaja, Stein Emil, Vollset, Elisabete, Weiderpass, Edward N, Libby, Christina, Fitzmaurice
Publikováno v:
JAMA oncology. 4(9)
Multiple myeloma (MM) is a plasma cell neoplasm with substantial morbidity and mortality. A comprehensive description of the global burden of MM is needed to help direct health policy, resource allocation, research, and patient care.To describe the b